Description
PRINCIPIO ACTIVO: PROMESTRIENO
Novartis Pharma AG
Riesgo de reactivación de hepatitis B al suspender el medicamento
PRINCIPIO ACTIVO: ACIDO IBANDRONICO
OHRENCIA 125 MG/ML | Solución Inyectable | 4 Jeringas Prellenadas | Bristol-Myers Squibb
BROXOFFLER 1 SOL 300MG/5/120 ML SERTRALINA 50.00 MG PRINCIPIO ACTIVO: PROMESTRIENO
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
